InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score48
United States Fiscal year ends December CIK 0000873303 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Michael Andrew Chambers
16 Aug 2024
Director
Buy indirect
5,648
$134.66
$760.56K
Michael Andrew Chambers
16 Aug 2024
Director
Buy indirect
18,284
$134.06
$2.45M
Michael Andrew Chambers
16 Aug 2024
Director
Buy indirect
13,106
$133.07
$1.74M
Douglas S Ingram
3 Nov 2023
President & CEO
Buy
200
$81.26
$16.25K
Douglas S Ingram
3 Nov 2023
President & CEO
Buy
3,884
$80.33
$312.00K
Douglas S Ingram
3 Nov 2023
President & CEO
Buy
11,060
$79.70
$881.48K
Douglas S Ingram
3 Nov 2023
President & CEO
Buy
10,081
$78.57
$792.06K
Richard Barry
3 Nov 2023
Director
Buy indirect
40,000
$78.81
$3.15M
Richard Barry
3 Nov 2023
Director
Buy indirect
10,000
$78.81
$788.10K
Michael Andrew Chambers
14 Aug 2023
Director
Buy indirect
4,032
$109.89
$443.08K
Michael Andrew Chambers
14 Aug 2023
Director
Buy indirect
5,947
$109.19
$649.35K
Michael Andrew Chambers
11 Aug 2023
Director
Buy indirect
23,686
$108.05
$2.56M
Michael Andrew Chambers
10 Aug 2023
Director
Buy indirect
31,570
$106.26
$3.35M
Michael Andrew Chambers
10 Aug 2023
Director
Buy indirect
1,091
$105.90
$115.54K
Michael Andrew Chambers
10 Aug 2023
Director
Buy indirect
2,206
$104.67
$230.90K
Michael Andrew Chambers
14 Sep 2022
Director
Buy
6,250
$105.16
$657.25K
Michael Andrew Chambers
14 Sep 2022
Director
Buy
30,106
$104.67
$3.15M
Michael Andrew Chambers
14 Sep 2022
Director
Buy
20,744
$103.87
$2.15M
Michael Andrew Chambers
19 Aug 2022
Director
Buy
6,060
$108.80
$659.33K
Michael Andrew Chambers
19 Aug 2022
Director
Buy
40,110
$108.20
$4.34M
Louise Rodino-Klapac
24 Nov 2021
Head of R&D, CSO
Buy
3,780
$79.33
$299.87K
Douglas S Ingram
17 Nov 2021
President & CEO
Buy
25,026
$79.94
$2.00M
Richard Barry
13 Sep 2019
Director
Buy
3,309
$87.49
$289.50K
Richard Barry
12 Sep 2019
Director
Buy
1,691
$87.49
$147.95K
Michael W Bonney
9 Sep 2019
Director
Buy
2,000
$86.74
$173.48K
M Kathleen Behrens
6 Sep 2019
Director
Buy
2,500
$87.98
$219.95K
Richard Barry
20 Aug 2019
Director
Buy
5,000
$99.32
$496.59K
Richard Barry
14 Aug 2019
Director
Buy
3,700
$122.50
$453.25K
Douglas S Ingram
12 Aug 2019
President & CEO
Buy
7,792
$123.41
$961.61K
Douglas S Ingram
12 Aug 2019
President & CEO
Buy
8,460
$122.76
$1.04M
Richard Barry
12 Aug 2019
Director
Buy
1,300
$122.50
$159.25K
Douglas S Ingram
30 Oct 2018
President & CEO
Buy
3,134
$120.94
$379.03K
Douglas S Ingram
30 Oct 2018
President & CEO
Buy
13,561
$120.26
$1.63M
Douglas S Ingram
15 Aug 2018
President & CEO
Buy
16,000
$125.26
$2.00M
Douglas S Ingram
8 Nov 2017
President & CEO
Buy
38,138
$52.44
$2.00M
Douglas S Ingram
27 Jul 2017
President & CEO
Buy
47,058
$42.50
$2.00M
Show all 167 transactions →

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 63
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 4,825,682
Sales filed before the plan box existed 7
History held since 8 Feb 2007